Comparison of High-Throughput Biophysical Methods to Identify Stabilizing Excipients for a Model IgG2 Monoclonal Antibody: Conformational Stability and Kinetic Aggregation Measurements

被引:56
作者
Cheng, Weiqiang [2 ]
Joshi, Sangeeta B. [2 ]
He, Feng [1 ]
Brems, David N. [3 ]
He, Bing [3 ]
Kerwin, Bruce A. [1 ]
Volkin, David B. [2 ]
Middaugh, C. Russell [2 ]
机构
[1] Amgen Inc, Proc & Prod Dev, Seattle, WA 98119 USA
[2] Univ Kansas, Dept Pharmaceut Chem, Macromol & Vaccine Stabilizat Ctr, Lawrence, KS 66047 USA
[3] Amgen Inc, Proc & Prod Dev, Thousand Oaks, CA 91320 USA
关键词
monoclonal antibody; stability; formulation; excipients; biophysical techniques; protein formulation; protein aggregation; biopharmaceuticals characterization; protein structure; NUCLEATED-POLYMERIZATION MODEL; EMPIRICAL PHASE-DIAGRAMS; PROTEIN AGGREGATION; FORMULATION DEVELOPMENT; NONNATIVE AGGREGATION; THERMAL AGGREGATION; PHYSICAL STABILITY; ACIDIC CONDITIONS; COMPETING GROWTH; SUCROSE;
D O I
10.1002/jps.23076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The overall conformational stability of a model IgG2 monoclonal antibody (mAb) was examined as a function of temperature and pH using an empirical phase diagram approach. Stabilizing excipients were then identified based on high-throughput methods including (1) kinetic studies measuring aggregation via increases in optical density and (2) thermally induced structural transitions as measured by differential scanning calorimetry (DSC) and fluorescence spectroscopy. The kinetic profiles of antibody aggregation at 65 degrees C were pH dependent and correlated well with pH effects on secondary and tertiary structural transitions due to heat stress. For the screening of stabilizing excipients, the inhibition of the rate of protein aggregation at pH 4.5 at 65 degrees C, as represented by changes in optical density, was shown to have a clear trend with a modest correlation coefficient compared with the stabilizing effect of the same excipients on the conformational stability of the antibody as measured by DSC and tryptophan fluorescence spectroscopy. These results demonstrate the utility of combining high-throughput data from protein aggregation kinetic experiments and conformational stability studies to identify stabilizing excipients that minimize the physical degradation of an IgG2 mAb. (C) 2012 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101: 1701-1720, 2012
引用
收藏
页码:1701 / 1720
页数:20
相关论文
共 73 条
[1]   A Lumry-Eyring nucleated polymerization model of protein aggregation kinetics: 1. Aggregation with pre-equilibrated unfolding [J].
Andrews, Jennifer M. ;
Roberts, Christopher J. .
JOURNAL OF PHYSICAL CHEMISTRY B, 2007, 111 (27) :7897-7913
[2]   High-throughput screening of stabilizers for respiratory syncytial virus - Identification of stabilizers and their effects on the conformational thermostability of viral particles [J].
Ausar, Salvador F. ;
Espina, Marianela ;
Brock, Julie ;
Thyagarayapuran, Nagaraian ;
Repetto, Robert ;
Khandke, Lakshmi ;
Middaugh, C. Russell .
HUMAN VACCINES, 2007, 3 (03) :94-103
[3]   Conformational stability and disassembly of Norwalk virus-like particles - Effect of pH and temperature [J].
Ausar, Salvador F. ;
Foubert, Thomas R. ;
Hudson, Mary H. ;
Vedvick, Thomas S. ;
Middaugh, C. Russell .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) :19478-19488
[4]   Aggregation of Recombinant Human Botulinum Protein Antigen Serotype C in Varying Solution Conditions: Implications of Conformational Stability for Aggregation Kinetics [J].
Bai, Shujun ;
Manning, Mark Cornell ;
Randolph, Theodore W. ;
Carpenter, John F. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (03) :836-848
[5]   Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions [J].
Bhambhani, Akhilesh ;
Kissmann, Julian M. ;
Joshi, Sangeeta B. ;
Volkin, David B. ;
Kashi, Ramesh S. ;
Middaugh, C. Russell .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (03) :1120-1135
[6]   Nonnative Aggregation of an IgG1 Antibody in Acidic Conditions, Part 2: Nucleation and Growth Kinetics with Competing Growth Mechanisms [J].
Brummitt, Rebecca K. ;
Nesta, Douglas P. ;
Chang, Liuquan ;
Kroetsch, Andrew M. ;
Roberts, Christopher J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (06) :2104-2119
[7]   Nonnative Aggregation of an IgG1 Antibody in Acidic Conditions: Part 1. Unfolding, Colloidal Interactions, and Formation of High-Molecular-Weight Aggregates [J].
Brummitt, Rebecca K. ;
Nesta, Douglas P. ;
Chang, Liuquan ;
Chase, Susan F. ;
Laue, Thomas M. ;
Roberts, Christopher J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (06) :2087-2103
[8]   Use of microcalorimetry and its correlation with size exclusion chromatography for rapid screening of the physical stability of large pharmaceutical proteins in solution [J].
Burton, Lori ;
Gandhi, Rajesh ;
Duke, Gerald ;
Paborji, Mehdi .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2007, 12 (03) :265-273
[9]   Biophysical and Stabilization Studies of the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane Protein [J].
Cai, Sumin ;
He, Feng ;
Samra, Hardeep S. ;
de la Maza, Luis M. ;
Bottazzi, Maria E. ;
Joshi, Sangeeta B. ;
Middaugh, C. Russell .
MOLECULAR PHARMACEUTICS, 2009, 6 (05) :1553-1561
[10]   Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality [J].
Carpenter, John F. ;
Randolph, Theodore W. ;
Jiskoot, Wim ;
Crommelin, Daan J. A. ;
Middaugh, C. Russell ;
Winter, Gerhard ;
Fan, Ying-Xin ;
Kirshner, Susan ;
Verthelyi, Daniela ;
Kozlowski, Steven ;
Clouse, Kathleen A. ;
Swann, Patrick G. ;
Rosenberg, Amy ;
Cherney, Barry .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (04) :1201-1205